Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Free Cash Flow: 2013-2025

Historic Free Cash Flow for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to -$4.5 million.

  • Phibro Animal Health's Free Cash Flow fell 248.21% to -$4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.3 million, marking a year-over-year decrease of 15.70%. This contributed to the annual value of $41.8 million for FY2025, which is 9.76% down from last year.
  • According to the latest figures from Q3 2025, Phibro Animal Health's Free Cash Flow is -$4.5 million, which was down 155.40% from $8.1 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Free Cash Flow peaked at $35.4 million during Q1 2025, and registered a low of -$33.9 million during Q3 2022.
  • For the 3-year period, Phibro Animal Health's Free Cash Flow averaged around $8.3 million, with its median value being $8.1 million (2025).
  • As far as peak fluctuations go, Phibro Animal Health's Free Cash Flow plummeted by 833.68% in 2022, and later soared by 2,011.39% in 2025.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Free Cash Flow stood at $12.4 million in 2021, then plummeted by 199.00% to -$12.3 million in 2022, then spiked by 267.36% to $20.6 million in 2023, then plummeted by 123.04% to -$4.7 million in 2024, then plummeted by 248.21% to -$4.5 million in 2025.
  • Its Free Cash Flow stands at -$4.5 million for Q3 2025, versus $8.1 million for Q2 2025 and $35.4 million for Q1 2025.